Experience Premium Cannabis (EPC)

Experience Premium Cannabis (EPC) has demonstrated a fluctuating performance in the Tincture & Sublingual category within the Nevada market. In August 2023, EPC ranked 12th in this category, but slipped slightly to 13th in September and further to 16th in October. This could indicate a decrease in their market competitiveness during these months. However, in a positive turn of events, EPC bounced back in November, climbing to the 11th position. This shows a promising recovery and upward trend in their category ranking towards the end of the year.

When it comes to sales, EPC experienced a downward trajectory from August to October 2023, with sales figures dropping from $5633 to $3336. This aligns with their drop in category ranking during the same period. However, mirroring their ranking recovery in November, their sales also saw a significant increase, nearly doubling to reach $6988. While it's clear that EPC faced some challenges in the Tincture & Sublingual category within Nevada during this period, their ability to rebound in both ranking and sales in November is a positive sign. It's worth keeping an eye on EPC's performance in the coming months to see if this upward trend continues.

In the Tincture & Sublingual category within Nevada, Experience Premium Cannabis (EPC) has seen a fluctuating rank over the months of August to November 2023, moving from 12th to 13th, dropping to 16th, and then improving to 11th. This indicates a competitive market with brands such as Mary's Medicinals, 8 Fold, White Label, and Nour jostling for position. Notably, EPC's sales seem to have rebounded significantly in November after a dip in September and October. In contrast, 8 Fold, which had a significant sales surge in October, has seen a drop in November, despite improving its rank to 10th. Meanwhile, White Label has consistently maintained its rank in the top 10, indicating steady sales. Mary's Medicinals and Nour have seen slight improvements in their ranks but their sales have remained relatively stable.

In November 2023, the top-performing product from Experience Premium Cannabis (EPC) was the CBN Good Night Tincture (500mg CBN, 14ml), which maintained its number one rank from previous months. This product also saw a significant increase in sales, with 125 units sold, up from 65 in October. The second best-selling product was the CBD/THC 20:1 Breath Easy Tincture (400mg CBD, 20mg THC,14ml), which jumped back into the rankings after not being ranked in the previous two months. The CBD/THC 1:1 Golden Mylk Tincture (100mg CBD,100mg THC) slipped to third place, continuing its downward trend from the previous months. Overall, the rankings for EPC's top products have shown notable changes month to month, with the exception of the consistently popular CBN Good Night Tincture.